Chimin(SH:603222) Shang Hai Zheng Quan Bao·2025-08-19 20:44Core Viewpoint - The stock of Jimin Health Management Co., Ltd. experienced abnormal trading fluctuations, with a cumulative closing price increase exceeding 20% over two consecutive trading days, prompting a risk warning to investors [2][3]. Group 1: Stock Trading Abnormalities - The company's stock price increased by 53.78% from August 13 to August 19, 2025, with significant deviations from the market and sector trends [2][7]. - The stock's closing price deviation reached a cumulative value of 20% on August 18 and 19, 2025, qualifying as an abnormal trading situation under the Shanghai Stock Exchange rules [3][4]. Group 2: Company Verification and Confirmation - The company conducted a self-examination and confirmed that there were no significant changes in its main business or external operating environment, and no undisclosed major matters exist [4][5]. - The company received written confirmation from its controlling shareholder and actual controller, stating that there are no undisclosed major asset restructurings, share issuances, or significant transactions [4][5]. Group 3: Financial Performance Risks - The company reported a net loss of 59.71 million yuan for the fiscal year 2024 and anticipates a net loss between 55 million yuan and 46 million yuan for the first half of 2025, indicating a decline compared to the previous year [2][7]. - The recent stock price increase is not aligned with the company's fundamental performance, suggesting a risk of short-term price correction [2][7].